Factors Influencing Patient Decisions Regarding Treatments for Skin Growths: A Cross-Sectional Study
Variations in treatment modalities for skin growths contribute substantially to overall healthcare spending within dermatology. However, little is known regarding factors impacting patient decision-making when choosing a treatment modality. In this survey-based, cross-sectional study (n = 375, 81.9%...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2018-01-01
|
| Series: | Dermatology Research and Practice |
| Online Access: | http://dx.doi.org/10.1155/2018/3941347 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832552057603620864 |
|---|---|
| author | David G. Li Fan Di Xia Jasmine Rana Grace J. Young Forootan Alizadeh Cara Joyce Shinjita Das Arash Mostaghimi |
| author_facet | David G. Li Fan Di Xia Jasmine Rana Grace J. Young Forootan Alizadeh Cara Joyce Shinjita Das Arash Mostaghimi |
| author_sort | David G. Li |
| collection | DOAJ |
| description | Variations in treatment modalities for skin growths contribute substantially to overall healthcare spending within dermatology. However, little is known regarding factors impacting patient decision-making when choosing a treatment modality. In this survey-based, cross-sectional study (n = 375, 81.9% response rate), we asked patients to rate the importance of different treatment parameters for a nonfacial skin growth, further classified into five domains: efficacy, appearance, financial impact, visit duration, and productivity. Although patients generally prioritized treatment efficacy when selecting a treatment modality, they emphasized different aspects of the treatment experience as a function of age, gender, race, insurance status, and history of malignancy. Patients over age 50 were less likely to consider treatment impact on finances as being “important”, but more so efficacy and visit duration. Women were more likely to value efficacy and appearance. Patients without private insurance were more likely to cite efficacy and impact on productivity as being “important”. While the underlying reasons for these variations differ across patients, these findings help explain variations in treatment selection among patients choosing between treatments for skin growths and may ultimately lead to improved shared decision-making. |
| format | Article |
| id | doaj-art-f8d3f4819d5f4c8f8c84970097a691da |
| institution | Kabale University |
| issn | 1687-6105 1687-6113 |
| language | English |
| publishDate | 2018-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Dermatology Research and Practice |
| spelling | doaj-art-f8d3f4819d5f4c8f8c84970097a691da2025-02-03T05:59:42ZengWileyDermatology Research and Practice1687-61051687-61132018-01-01201810.1155/2018/39413473941347Factors Influencing Patient Decisions Regarding Treatments for Skin Growths: A Cross-Sectional StudyDavid G. Li0Fan Di Xia1Jasmine Rana2Grace J. Young3Forootan Alizadeh4Cara Joyce5Shinjita Das6Arash Mostaghimi7Department of Dermatology, Brigham & Women’s Hospital, Harvard Medical School, Boston, MA, USABrigham & Women’s Hospital, Harvard Medical School, Boston, MA, USASanta Clara Valley Medical Center, San Jose, CA, USAHarvard Medical School, Boston, MA, USABrigham & Women’s Hospital, Harvard Medical School, Boston, MA, USALoyola University, Chicago, IL, USADepartment of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USADepartment of Dermatology, Brigham & Women’s Hospital, Harvard Medical School, Boston, MA, USAVariations in treatment modalities for skin growths contribute substantially to overall healthcare spending within dermatology. However, little is known regarding factors impacting patient decision-making when choosing a treatment modality. In this survey-based, cross-sectional study (n = 375, 81.9% response rate), we asked patients to rate the importance of different treatment parameters for a nonfacial skin growth, further classified into five domains: efficacy, appearance, financial impact, visit duration, and productivity. Although patients generally prioritized treatment efficacy when selecting a treatment modality, they emphasized different aspects of the treatment experience as a function of age, gender, race, insurance status, and history of malignancy. Patients over age 50 were less likely to consider treatment impact on finances as being “important”, but more so efficacy and visit duration. Women were more likely to value efficacy and appearance. Patients without private insurance were more likely to cite efficacy and impact on productivity as being “important”. While the underlying reasons for these variations differ across patients, these findings help explain variations in treatment selection among patients choosing between treatments for skin growths and may ultimately lead to improved shared decision-making.http://dx.doi.org/10.1155/2018/3941347 |
| spellingShingle | David G. Li Fan Di Xia Jasmine Rana Grace J. Young Forootan Alizadeh Cara Joyce Shinjita Das Arash Mostaghimi Factors Influencing Patient Decisions Regarding Treatments for Skin Growths: A Cross-Sectional Study Dermatology Research and Practice |
| title | Factors Influencing Patient Decisions Regarding Treatments for Skin Growths: A Cross-Sectional Study |
| title_full | Factors Influencing Patient Decisions Regarding Treatments for Skin Growths: A Cross-Sectional Study |
| title_fullStr | Factors Influencing Patient Decisions Regarding Treatments for Skin Growths: A Cross-Sectional Study |
| title_full_unstemmed | Factors Influencing Patient Decisions Regarding Treatments for Skin Growths: A Cross-Sectional Study |
| title_short | Factors Influencing Patient Decisions Regarding Treatments for Skin Growths: A Cross-Sectional Study |
| title_sort | factors influencing patient decisions regarding treatments for skin growths a cross sectional study |
| url | http://dx.doi.org/10.1155/2018/3941347 |
| work_keys_str_mv | AT davidgli factorsinfluencingpatientdecisionsregardingtreatmentsforskingrowthsacrosssectionalstudy AT fandixia factorsinfluencingpatientdecisionsregardingtreatmentsforskingrowthsacrosssectionalstudy AT jasminerana factorsinfluencingpatientdecisionsregardingtreatmentsforskingrowthsacrosssectionalstudy AT gracejyoung factorsinfluencingpatientdecisionsregardingtreatmentsforskingrowthsacrosssectionalstudy AT forootanalizadeh factorsinfluencingpatientdecisionsregardingtreatmentsforskingrowthsacrosssectionalstudy AT carajoyce factorsinfluencingpatientdecisionsregardingtreatmentsforskingrowthsacrosssectionalstudy AT shinjitadas factorsinfluencingpatientdecisionsregardingtreatmentsforskingrowthsacrosssectionalstudy AT arashmostaghimi factorsinfluencingpatientdecisionsregardingtreatmentsforskingrowthsacrosssectionalstudy |